A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Treatment Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with numerous of members share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users injecting substances of unknown origin.
Some professionals said the demand for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.
Platform Reaction and Content Elimination
Based on TikTok, the service has removed problematic material and banned related hashtags and query recommendations. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also found groups with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, populated with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.
After moments of entering one community, a seller shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.
Item Information and Costs
Inside these groups, posts display dark colored parcels with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service said it regularly monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Although the science behind this drug is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to potentially serious health risks”.
